Skip to content
★ Sign in to follow
XRF Scientific Limited logo

XRF Scientific Limited Stock: price and insider trades · Australia

ISIN AU000000XRF8AU·Mcap A$306.6MIndustrials

3 insiders bought €44k of shares over the last 90 days, the latest by Vance Stazzonelli, filed 03 Nov 2026.

Cluster: 2 buyers in 30 days

XRF Scientific Limited: what insiders have been doing

Every trade that managers of XRF Scientific Limited disclose to ASX is tracked on this page. The company sits in the Industrials sector. From 3 November 2025 to 3 November 2026, the disclosure feed for XRF Scientific Limited logged 8 filings by 4 insiders.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €44k, made by 3 insiders. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Frederick Sheppard Grimwade filed the largest purchase, €16k, on 28 September 2026, which represents 0.010% of the company's market value. On the buying side, the filings list 3 senior executives among the declarants.

Within a 30-day window, 2 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 3 November 2026, 5 days ago. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public.

Across the 1,619 companies tracked on its exchange, the median is 5 filings; at 8 filings, this issuer sits above that mark. Our records for XRF Scientific Limited go back to 2026, with 6 purchases and no sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Auroora Yhtiöt Oyj and MBB SE. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Insider Decl.
8
Thresholds
n/a
Buy Volume
€43,578
6 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Vance Stazzonelli3 buys
Frederick Sheppard Grimwade2 buys
David William Kiggins1 buy

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 7,304 of 26,914 companies
63.0
score / 100
Value
45
Quality
81
FCF yld2.9%
Earn yld3.5%
EV/EBITDA17.6x
ROE17%
Gross mgn49%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$2.12
Analyst consensus
1 analysts
1.00/5
A$2.37Target A$2.37(+12%)A$2.37
Income statement
RevenueA$64.1M
Gross profitA$31.5M49% margin
EBITDAA$17.2M27% margin
Net incomeA$10.5M16.3% margin
Valuation
PER (trailing)30.3x
PER (forward)20.4x
P/Book4.6x
Beta0.70
Balance sheet & cash
Market capA$306.6M
Total debtA$2.3M
Free Cash FlowA$8.8M
Debt / Equity4%
Profitability & ownership
ROE16.6%
ROA12.8%
% insiders29.9%
% institutions6.0%
Last declaration on 3 November 2026
Declarations8 total
  • ▲
    DirectorExecutives
    0ASX
    174,226 sharesShareASXISIN AU000000XRF8ASX:2924-03157557-6A1353441
    Canonical exit: 31 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    13,024 AUD31ASX
    6,900 shares@ A$1.88750.0048% mcap34.2% of flowShareASXASX:2924-03151205-6A1350458
    Canonical exit: 19 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    4,150 AUD38ASX
    2,385 shares@ A$1.740.0017% mcap100.0% of flowShareASXISIN AU000000XRF8ASX:2924-03140671-6A1346033
    Canonical exit: 24 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    25,357 AUD25ASX
    14,573 shares@ A$1.740.010% mcap100.0% of flowShareASXISIN AU000000XRF8ASX:2924-03140669-6A1346032
    Canonical exit: 24 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    18,268 AUD23ASX
    10,000 shares@ A$1.82680.0058% mcap64.9% of flowShareASXASX:2924-03125789-6A1340160
    Canonical exit: 23 Nov 2026 (T+90)
  • ▲
    DirectorExecutives
    9,865 AUD21ASX
    5,366 shares@ A$1.83840.0031% mcap35.1% of flowShareASXASX:2924-03124977-6A1339910
    Canonical exit: 22 Nov 2026 (T+90)
  • ●
    DirectorExecutives
    0ASX
    0ShareASXISIN AU000000XRF8ASX:2924-03124234-6A1339652
  • ●
    DirectorExecutives
    13,800 AUD19ASX
    0@ A$1.84100.0% of flowShareASXASX:2924-03102929-6A1330588

8 of 8 declarations

About XRF Scientific Limited

XRF Scientific Limited is an Australian company that specializes in the manufacture and distribution of analytical instruments and chemical products for the mining and metallurgical industries. It is listed on the Australian Securities Exchange (ASX).

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations